Nu Skin Enterprises, Inc. (NUS)
| Market Cap | 370.79M +17.3% |
| Revenue (ttm) | 1.49B -14.3% |
| Net Income | 160.20M |
| EPS | 3.18 |
| Shares Out | 49.18M |
| PE Ratio | 2.37 |
| Forward PE | 7.54 |
| Dividend | $0.24 (3.18%) |
| Ex-Dividend Date | Feb 27, 2026 |
| Volume | 330,175 |
| Open | 7.43 |
| Previous Close | 7.46 |
| Day's Range | 7.41 - 7.56 |
| 52-Week Range | 5.43 - 14.62 |
| Beta | 1.07 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 7, 2026 |
About NUS
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands. The company also provides wellness products, such as ageLOC TRME, LifePak, and Beauty Focus. In... [Read more]
Financial Performance
Financial StatementsNews
Nu Skin Enterprises to Announce First Quarter 2026 Financial Results
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release first quarter 2026 results after the market closes on Thursday, May 7. The Nu Skin management team w...
Nu Skin Launches Prysm iO™: A Revolutionary AI-Powered Platform for Personalized Nutritional Wellness
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS), the world's #1 company for beauty and wellness device systems,* today announced the general consumer availability in the U.S. of Pry...
Nu Skin Enterprises Appoints Chelsea Lantz as Interim Chief Financial Officer
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced the appointment of Chelsea Lantz as interim Chief Financial Officer, effective immediately. The appointment of Lantz...
Nu Skin Appoints Chayce Clark as COO
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE:NUS) today announced the appointment of Chayce Clark as chief operating officer effective immediately. Clark will be responsible for leadin...
Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2025 Q4
Dallas, Texas--(Newsfile Corp. - February 13, 2026) - NU Skin Enterprises Inc. (NYSE: NUS): Stonegate Capital Partners updates their coverage on NU Skin Enterprises Inc. (NYSE: NUS). NUS reported reve...
Top 3 Defensive Stocks That May Rocket Higher In February
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
Nu Skin Enterprises Earnings Call Transcript: Q4 2025
Q4 and full-year 2025 results met guidance, with EPS up 51% and a 40% stock price increase. 2026 outlook anticipates growth from Prysm iO's global launch and India expansion, with revenue guidance of $1.35–$1.5 billion and EPS of $0.80–$1.20.
Nu Skin Enterprises Reports Fourth Quarter and Full-year 2025 Results Within Guidance
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS) today announced fourth quarter and full-year 2025 revenue and earnings within guidance with more than 50% growth in earnings for 2025...
Nu Skin Enterprises Announces Quarterly Dividend
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced its board of directors has declared a quarterly cash dividend of $0.06 per share, which will be paid on Mar. 11, 202...
Dr. Joseph Chang Launches Update to Bestselling Book "The Aging Myth" With 15 More Years of Breakthrough Research on Cellular Wellness
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS) today announced the relaunch of “The Aging Myth: Unlocking the Mysteries of Looking and Feeling Young,” the updated edition of the be...
5 Undervalued Safe-Haven Stocks with Strong Dividends
Fighting fire with fire is rarely a winning strategy for investors. When markets are volatile and geopolitical tension soars, it seldom makes sense to invest in speculative assets or risky pre-profit ...
Nu Skin Enterprises to Announce Fourth Quarter and Full Year 2025 Financial Results
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS) today announced it will release fourth quarter and full year 2025 results after the market closes on Thursday, Feb. 12. The Nu Skin m...
Nu Skin Enterprises Transcript: 28th Annual ICR Conference 2026
The company is leveraging IoT and AI to deliver personalized wellness solutions, with Prysm iO set to drive recurring revenue and growth. Expansion in India and Latin America, along with a balanced global footprint, positions the business for long-term stability and value creation.
Nu Skin Enterprises to Discuss Company Strategy and Opportunities at ICR Conference
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS) today announced president and CEO Ryan Napierski will participate in a moderated fireside chat to discuss company strategy and the st...
Nu Skin Releases 2024 Social Impact and Sustainability Report
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS), a global intelligent beauty and wellness leader, today released its 2024 Social Impact and Sustainability Report. The report outlin...
Nu Skin Unveils Prysm iO™: An Evolution in Intelligent Nutritional Wellness
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS), the world's #1 company for beauty and wellness device systems*, introduced Prysm iO™, a breakthrough intelligent nutritional wellnes...
Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2025 Q3
Dallas, Texas--(Newsfile Corp. - November 7, 2025) - NU Skin Enterprises Inc. (NYSE: NUS): Stonegate Capital Partners updates their coverage on NU Skin Enterprises Inc. (NYSE: NUS). NUS reported reven...
Nu Skin Enterprises Earnings Call Transcript: Q3 2025
Q3 revenue and EPS met or exceeded guidance, driven by strong Latin America growth and margin improvements, while North America faced challenges. Strategic launches of Prism iO and entry into India are set to drive future growth, with profitability and innovation as ongoing priorities.
Nu Skin Enterprises Reports Third Quarter Earnings
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS) today announced third quarter revenue and earnings per share within its guidance range. Executive Summary Q3 2025 vs. Prior-year Quar...
Nu Skin Enterprises to Announce Third Quarter 2025 Financial Results
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release third quarter 2025 results after the market closes on Thursday, Nov. 6. The Nu Skin management team ...
Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Second Consecutive Year
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS), a global beauty and wellness leader, has been ranked the world's No. 1 company for beauty and wellness device systems by Euromonitor...
Stonegate Capital Partners Initiates Coverage on NU Skin Enterprises Inc. (NUS)
Dallas, Texas--(Newsfile Corp. - August 8, 2025) - Skin Enterprises Inc. (NYSE: NUS): Stonegate Capital Partners initiates their coverage on Skin Enterprises Inc. (NYSE: NUS). NUS reported revenue, ad...
Nu Skin Enterprises Earnings Call Transcript: Q2 2025
Q2 2025 revenue reached $386.1M with EPS of $0.43, driven by strong cost management and growth in Latin America. Guidance for 2025 was narrowed amid global uncertainties, with innovation and developing markets as key priorities.
Nu Skin Enterprises Reports Second Quarter Revenue at High End of Guidance and Earnings Per Share Above Guidance
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS) today announced second quarter revenue at the high end of its guidance range and earnings per share exceeding guidance. Executive Sum...
Nu Skin Enterprises to Announce Second Quarter 2025 Financial Results
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release second quarter 2025 results after the market closes on Thursday, Aug. 7. The Nu Skin management team...